|

Project Dulce for Arab Americans With Type 2 Diabetes

RECRUITINGN/ASponsored by Scripps Whittier Diabetes Institute
Actively Recruiting
PhaseN/A
SponsorScripps Whittier Diabetes Institute
Started2023-02-17
Est. completion2026-06-30
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites

Summary

Arab Americans (AA) face many challenges in diabetes self-management due to the limited educational resources and support available for them. The cultural and linguistic barriers between patients and health care providers lead to poor diabetes management and outcomes. This study (Project Dulce Arabic) is adapted from the Project Dulce, an American Diabetes Association (ADA)-recognized Diabetes Self-Management Education Support (DSMES) program. Project Dulce Arabic comprises both peer-led diabetes education in Arabic and a 3-month text messaging program (Dulce Digital). The main aim of the study is to examine the effectiveness of a more culturally and linguistically appropriate diabetes education program in improving diabetes knowledge, beliefs, and self-management as well as hemoglobin A1C.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Are a participant of Metro Caring
* Self-identified Arab
* Diagnosed with type 2 diabetes mellitus (T2DM)
* HbA1c ≥7.5% in the last 30 days
* Able to speak, read, write, and comprehend in English and Arabic
* Have access to a cell phone that can receive/send text messages throughout the study

Exclusion Criteria:

* Pregnant
* Are currently participating in another diabetes-related study

Conditions2

DiabetesDiabetes Mellitus, Type 2

Locations2 sites

California

1 site
San Ysidro Health
El Cajon, California, 92020

Colorado

1 site
Metro Caring
Denver, Colorado, 80218
Lannea Hand, MS, RDN720-860-7200LHand@metrocaring.org

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.